Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Study highlights value of cognitive training for adults with mild cognitive impairment

Study highlights value of cognitive training for adults with mild cognitive impairment

Researchers use experimental PET to detect abnormal tau in brains of living former NFL players

Researchers use experimental PET to detect abnormal tau in brains of living former NFL players

Atrium Health and Wake Forest signs MOU to create next-generation healthcare system

Atrium Health and Wake Forest signs MOU to create next-generation healthcare system

Stimulating parvalbumin-containing cells causes surprising changes in blood volume, flow

Stimulating parvalbumin-containing cells causes surprising changes in blood volume, flow

Scientists develop technique to clear abnormal tau protein from human neurons

Scientists develop technique to clear abnormal tau protein from human neurons

Researchers develop new method for identifying compounds that prevent aging

Researchers develop new method for identifying compounds that prevent aging

Gum disease bacterium releases toxins that may cause Alzheimer's

Gum disease bacterium releases toxins that may cause Alzheimer's

New research finds anti-inflammatory drugs to be ineffective to prevent Alzheimer’s

New research finds anti-inflammatory drugs to be ineffective to prevent Alzheimer’s

NSAIDs ineffective for treatment or prevention of Alzheimer's disease

NSAIDs ineffective for treatment or prevention of Alzheimer's disease

Vascular changes in the eye reveal early cognitive impairment

Vascular changes in the eye reveal early cognitive impairment

Scientists to investigate link between sleep and dementia at UEA’s new sleep unit

Scientists to investigate link between sleep and dementia at UEA’s new sleep unit

PET images of microglial activation levels could better predict Alzheimer's disease progression

PET images of microglial activation levels could better predict Alzheimer's disease progression

Developing imaging techniques for early detection of eye and brain diseases

Developing imaging techniques for early detection of eye and brain diseases

Drug that looks at Alzheimer’s differently ready for its first in-human testing

Drug that looks at Alzheimer’s differently ready for its first in-human testing

ADDF’s new initiative aims to advance digital tools for Alzheimer's and dementias

ADDF’s new initiative aims to advance digital tools for Alzheimer's and dementias

Simplifying Gene Expression Analysis in Neuroscience Research

Simplifying Gene Expression Analysis in Neuroscience Research

PET scans could be used to develop best practices for dementia

PET scans could be used to develop best practices for dementia

New study debunks link between depression risk and 18 genes

New study debunks link between depression risk and 18 genes

UCL scientists discover key brain region for navigating familiar places

UCL scientists discover key brain region for navigating familiar places

Scientists identify two, extremely rare genetic variants linked to Alzheimer disease

Scientists identify two, extremely rare genetic variants linked to Alzheimer disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.